BSUBall State University · Chemistry
Nucleic Acid Nanotechnology Lab
Emil Khisamutdinov · Muncie, Indiana
Research Focus
Dr. Emil Khisamutdinov's lab focuses on creating innovative alternatives to traditional monoclonal antibodies using nucleic acid technology. By developing nanoparticles that mimic antibodies, the lab aims to improve detection and treatment methods for prostate cancer while reducing production costs and overcoming some limitations of existing therapies. The research integrates engineering with molecular biology to design stable, programmable materials that could revolutionize therapeutic approaches in cancer treatment.
Nucleic acid nanotechnologyMonoclonal antibody mimicsProstate cancerAptamer technologyNanoparticles
Research Aims
3AIM 01Construct and characterize next-gen nucleic acid nanoparticles as antibody mimics
AIM 02Evaluate the stability and binding affinity of these nanoparticles to prostate cancer markers
AIM 03Assess the specificity of the nanoparticles to prostate cancer cells
Skills the Lab Values
DNA nanotechnologyCell cultureAptamer selectionAtomic force microscopyIn vitro binding assays
Output against the department
Publications40bottom 7% of dept.200th of 216
this lab
most publishedleast published
Citations1.4kbottom 10% of dept.194th of 216
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.